https://www.evernorth.com/articles/cell-and-gene-therapy-pipeline-outlook-for-plan-sponsors
Gene therapy pipeline outlook for plan sponsors | Evernorth
May 1, 2026 - Gene therapy’s expansion into oncology, cardiometabolic, and neurology is reshaping how plan sponsors approach long-term benefit strategy. Learn more.
gene therapy pipelinefor plan sponsorsoutlookevernorth